GOP Doctors Caucus Endorses Legislation to Reduce the Cost of Lifesaving Drugs

Washington, D.C. - Today, the GOP Doctors Caucus announces its endorsement of H.R.4317, the PBM Reform Act, bipartisan legislation to reduce the cost of lifesaving drugs for patients.

"Pharmacy Benefit Managers (PBMs) are middlemen that drive up the cost of lifesaving drugs for patients," said Co-Chairs Rep. Greg Murphy, M.D. & Rep. John Joyce, M.D. "Reform is long overdue to rein in the abuse of PBMs, which prioritize profits over patients through shady practices such as pushing high-cost drugs, limiting consumer access, monopolizing the market, and reimbursing pharmacies at unacceptable rates. This legislation will make much-needed reforms to put patients first."

Background
H.R.4317, the PBM Reform Act, would increase transparency, reduce costs, and improve patient access by banning spread pricing in Medicaid, delinking PBM compensation from drug costs, increasing transparency in drug pricing, drug spending, rebates, and formulary decisions, and enhancing federal oversight.